Drilldown: Medicines
Appearance
Use the filters below to narrow your results.
Dissociative (1) ·
Research material (2) ·
SSRI)]] (1) ·
Stimulant (1) ·
[[:Category:Antidepressants|Antidepressant (fluoxetine (1) ·
[[:Category:Fixed-dose_combinations|Fixed-dose combination]] (1) ·
[[:Category:Mood_stabilizers|Mood stabilizer]] (1) ·
[[:Category:Neuroleptics|Atypical neuroleptic (olanzapine)]] (1)
Alpha-methylated amphetamine analogue; norepinephrine releasing agent (1) ·
NMDA antagonist; fluorinated ketamine analogue (1) ·
'"`UNIQ--vote-00001549-QINU`"' Metabolic effects (weight gain, dyslipidemia, glucose dysregulation) dominate the long-term tolerability profile; routine metabolic monitoring is standard'"`UNIQ--ref-0000154A-QINU`"'. (1)
Showing below up to 3 results in range #1 to #3.


